Needham Ups ALNY To Buy
Analysts at Needham upgrade Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) from “hold” to “buy.” The target price for ALNY is set to $16.
ALNY shares dropped 1.76% to close at $11.17 yesterday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.